Schroder Investment Management Group Hutchmed (China) LTD Transaction History

Schroder Investment Management Group

$83.3 Billion
Q1 2024

A detailed history of Schroder Investment Management Group transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Schroder Investment Management Group holds 3,849,793 shares of HCM stock, worth $65.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,849,793

Previous 4,179,836 7.9%

Holding current value

$65.9 Million

Previous $75.7 Million 14.56%

% of portfolio

0.08%

Previous 0.1%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$12.08 - $18.56 $3.99 Million - $6.13 Million	-330,043 Reduced 7.9%	3,849,793 $64.7 Million
Q4 2023 Feb 13, 2024	SELL	$16.25 - $20.23 $639,145 - $795,686	-39,332 Reduced 0.93%	4,179,836 $75.7 Million
Q3 2023 Nov 14, 2023	SELL	$11.85 - $16.95 $4.54 Million - $6.5 Million	-383,503 Reduced 8.33%	4,219,168 $71.5 Million
Q2 2023 Aug 11, 2023	BUY	$10.78 - $17.73 $369,829 - $608,263	34,307 Added 0.75%	4,602,671 $55.2 Million
Q1 2023 May 11, 2023	SELL	$13.02 - $19.87 $1.15 Million - $1.76 Million	-88,420 Reduced 1.9%	4,568,364 $59.5 Million

Q4 2022 Feb 10, 2023	BUY	$7.65 - $15.51 $2.42 Million - $4.91 Million	316,388 Added 7.29%	4,656,784 $68.8 Million
Q3 2022 Nov 10, 2022	BUY	$8.63 - $15.52 $7.39 Million - $13.3 Million	855,777 Added 24.56%	4,340,396 $38.5 Million
Q2 2022 Aug 11, 2022	BUY	$8.59 - $20.77 $639,886 - $1.55 Million	74,492 Added 2.18%	3,484,619 $44 Million
Q1 2022 May 16, 2022	BUY	$15.52 - $35.65 $4.78 Million - $11 Million	308,084 Added 9.93%	3,410,127 $67.5 Million
Q4 2021 Feb 14, 2022	BUY	$28.89 - $35.33 $2.08 Million - $2.54 Million	71,992 Added 2.38%	3,102,043 $21.8 Million
Q3 2021 Nov 12, 2021	BUY	$35.66 - $42.94 $68.8 Million - $82.9 Million	1,930,312 Added 175.52%	3,030,051 $22.2 Million
Q2 2021 Aug 13, 2021	SELL	$23.7 - $39.27 $69.1 Million - $115 Million	-2,915,949 Reduced 72.61%	1,099,739 $43.2 Million
Q1 2021 May 17, 2021	BUY	$27.01 - $36.8 $2.69 Million - $3.67 Million	99,643 Added 2.54%	4,015,688 $113 Million
Q4 2020 Feb 16, 2021	BUY	$27.51 - $34.36 $2.88 Million - $3.6 Million	104,791 Added 2.75%	3,916,045 $125 Million
Q3 2020 Nov 13, 2020	SELL	$25.8 - $34.61 $6.12 Million - $8.21 Million	-237,138 Reduced 5.86%	3,811,254 $122 Million
Q2 2020 Aug 13, 2020	BUY	$17.65 - $28.05 $1.14 Million - $1.81 Million	64,482 Added 1.62%	4,048,392 $112 Million
Q1 2020 May 15, 2020	BUY	$15.19 - $29.51 $19.5 Million - $37.9 Million	1,285,243 Added 47.63%	3,983,910 $72.8 Million
Q4 2019 Feb 11, 2020	BUY	$17.17 - $25.95 $6.08 Million - $9.19 Million	354,022 Added 15.1%	2,698,667 $67.7 Million
Q3 2019 Nov 12, 2019	BUY	$17.84 - $22.69 $12.7 Million - $16.2 Million	714,434 Added 43.82%	2,344,645 $42.1 Million
Q2 2019 Aug 08, 2019	SELL	$22.0 - $31.78 $4.84 Million - $6.99 Million	-219,813 Reduced 11.88%	1,630,211 $35.9 Million
Q1 2019 May 14, 2019	BUY	$21.27 - $30.58 $979,887 - $1.41 Million	46,069 Added 2.55%	1,850,024 $56.6 Million
Q3 2018 Nov 13, 2018	BUY	$26.55 - $34.38 $7.65 Million - $9.91 Million	288,315 Added 19.02%	1,803,955 $58.1 Million
Q2 2018 Aug 13, 2018	BUY	$27.79 - $34.49 $6.51 Million - $8.08 Million	234,197 Added 18.28%	1,515,640 $46.3 Million
Q1 2018 May 11, 2018	BUY	$28.87 - $41.13 $3.67 Million - $5.23 Million	127,279 Added 11.03%	1,281,443 $37.9 Million
Q4 2017 Feb 09, 2018	BUY	$27.41 - $39.42 $4.3 Million - $6.19 Million	157,000 Added 15.74%	1,154,164 $45.5 Million
Q3 2017 Nov 09, 2017	BUY	$22.15 - $27.5 $22.1 Million - $27.4 Million	997,164	997,164 $27.2 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

14M

Call Options Held

2.7K

Put Options Held

3.7K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.96B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Hutchmed (China) LTD Transaction History